Herlev Hospital
Records under this name other than the patents Herlev Hospital holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,648,302 | Indoleamine 2,3-dioxygenase based immunotherapy Formerly held In force · USPTO record | In force | USPTO record | |
| US 12,233,103 | Indoleamine 2,3-dioxygenase based immunotherapy Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,324,813 | Indoleamine 2,3-dioxygenase based immunotherapy Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,258,678 | Indoleamine 2,3-dioxygenase based immunotherapy Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,433,666 | Indoleamine 2,3-dioxygenase based immunotherapy Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,669,078 | PD-L1 based immunotherapy Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,402,373 | General Detection and Isolation of Specific Cells by Binding of Labeled Molecules Formerly held In force · High confidence | In force | High confidence | |
| US 11,585,806 | General Detection and Isolation of Specific Cells by Binding of Labeled Molecules Formerly held In force · High confidence | In force | High confidence | |
| US 11,668,705 | General Detection and Isolation of Specific Cells by Binding of Labeled Molecules Formerly held In force · High confidence | In force | High confidence | |
| US 10,736,950 | Vaccine compositions comprising tryptophan 2,3-dioxygenase or fragments thereof Formerly held In force · USPTO record | In force | USPTO record |